Therefore, the primary objective of this study was to comprehensively summarise the available evidence on the potential effectiveness and safety of TNF-α inhibitors in the treatment of moderate-to-critical COVID-19 in inhibitor-naïve patients. This evidence concerns the gene TNF and COVID-19.